Neuraly ^Company

Clinical-stage biotechnology companyВідповідно до джерел: 3Neuraly is a clinical-stage biotechnology company whose mission is to translate scientific discoveries in neurology into new drugs that can radically improve and prolong the lives of people suffering from the devastating consequences of diseases such as Parkinson’s disease (PD), Alzheimer’s - is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. It offers treatments for Parkinson’s disease (PD), Alzheimer’s disease (AD), and other neurodegenerative Company Profile - … is a clinical-stage biotechnology company focused on developing disease-modifying agents for neurodegenerative disorders. Their focus is on the glial and microglial cells of the -